This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Priapism

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Priapism is persistent painful erection in the absence of sexual desire (priapism is defined as a prolonged and persistent penile erection, unassociated with sexual interest or stimulation, lasting longer than 4 hours)

  • priapism (an erection lasting >4 hours) results in 5.3 emergency department visits per 100,000 patient-years in the US (1)

  • up to 42% of men with SCD (sickle cell disease) experience priapism during their lifetime (1)

  • are three major types of priapism: ischemic, nonischemic, and stuttering (2,3,4)
    • establishing the type of priapism is paramount to safely and effectively treating these episodes. Ischemic priapism (low flow priapism) represents a urological emergency:
      • acute ischemic priapism (IP) is an emergent condition requiring urgent intervention within 6 to 12 hours of onset to prevent permanent erectile dysfunction, penile fibrosis, and penile shortening (1)
      • ichemic priapism may be caused by certain oral medications (eg, trazodone), injections used for erectile dysfunction (eg, alprostadil), illicit drug use (eg, amphetamines), or sickle cell disease (5)
        • ischemic priapism, also termed veno-occlusive or low flow priapism, is a persistent erection marked by rigidity of the corpora cavernosa and little or no cavernous arterial inflow
        • treatment may involve aspiration/irrigation with sympathomimetic injections, surgical shunts, and as a last resort, penile prosthesis implantation (2)

      • nonischemic priapism (high flow priapism) results from continuous flow of arterial blood into the penis, most commonly related to penile trauma
        • also termed arterial or high-flow priapism, is a persistent erection caused by unregulated cavernous arterial inflow
        • generally occurs as a result of trauma, creating a disruption in the cavernous arterial anatomy, resulting in an arteriolar-sinusoidal fistula
        • cavernous environment does not become ischemic secondary to the continuous influx of arterial blood
        • occurs when there is a persistent increase in blood flow into the penis without decreased outflow, which results in a prolonged, nonpainful, partially rigid erection (5)
        • veno-occlusive mechanism is usually intact and the patients experience erections of a more elastic consistency (3)
          • tissue anoxia and ischaemia are characteristically absent, there is absence of pain, and there is less chance of future erectile dysfunction, in contrast with low flow priapism
        • can occur secondary to:
          • congenital arterial malformations
          • iatrogenic insults
          • as a persistent high-flow state after shunt procedures for ischemic priapism
        • is not an emergency and may be managed conservatively initially, as most of these episodes are self-limiting (2)

      • stuttering priapism involves recurrent self-limiting episodes of ischemic priapism (2)
        • both stuttering and ischemic priapism result in the same consequence, namely, ischemic damage to the corporal tissue

  • in patients presenting with priapism, clinicians should complete a medical, sexual, and surgical history, and perform a physical examination, which includes the genitalia and perineum (4)

  • clinicians should obtain a corporal blood gas at the initial presentation of priapism (4)

  • clinicians may utilize penile duplex Doppler ultrasound when the diagnosis of acute ischemic versus non-ischemic priapism is indeterminate (4)

  • primary goal of therapy is prevention, but acute episodes should be managed in accordance with guidelines for ischemic priapism

Management of ischemic priapism

  • is a urological emergency
    • in a patient with diagnosed acute ischemic priapism, conservative therapies (i.e., observation, oral medications, cold compresses, exercise) are unlikely to be successful and should not delay definitive therapies (4)
    • clinicians should counsel all patients with persistent acute ischemic priapism that there is the chance of erectile dysfunction (4)
    • first-line therapy for patients with episodes of acute ischemic priapism is aspiration of blood with irrigation of the corpora cavernosa, in combination with intracavernous alpha-agonist injection therapy (2)
    • for priapism specifically related to SCD (sickle cell disease), medical therapies such as intravenous hydration, oxygenation, alkalinization, and exchange transfusion may be performed (2)
      • note that these interventions should never precede the first-line treatment for all episodes of ischemic priapism mentioned above
    • surgical management (3)
      • is used if conservative measures fail
      • aim of surgical treatment is to provide a shunt between the corpus cavernosum and glans penis, corpus spongiosum or a vein so that the obstructed venoocclusive mechanism is bypassed

Reference:

  • Fantus RJ, Brannigan RE, Davis AM. Diagnosis and Management of Priapism. JAMA. Published online July 20, 2023. doi:10.1001/jama.2023.13377
  • Levey HR, Segal RL, Bivalacqua TJ. Management of priapism: an update for clinicians. Ther Adv Urol. 2014 Dec;6(6):230-44. doi: 10.1177/1756287214542096. PMID: 25435917; PMCID: PMC4236300.
  • Cherian J, Rao AR, Thwaini A, Kapasi F, Shergill IS, Samman R. Medical and surgical management of priapism. Postgrad Med J. 2006 Feb;82(964):89-94. doi: 10.1136/pgmj.2005.037291. PMID: 16461470; PMCID: PMC2596691.
  • Bivalacqua TJ, Allen BK, Brock GB, et al. The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA/SMSNA guideline. J Urol. 2022;208(1):43-52.
  • Asanad K, Halpern JA, Brannigan RE. What Is Priapism? JAMA. Published online March 21, 2024. doi:10.1001/jama.2023.26934

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.